Show Summary Details
Page of

Ethical and Legal Considerations 

Ethical and Legal Considerations
Chapter:
Ethical and Legal Considerations
Author(s):

Annette Flanagin

DOI:
10.1093/jama/9780190246556.003.0005
Page of

PRINTED FROM AMA MANUAL OF STYLE ONLINE (www.amamanualofstyle.com). © American Medical Association, 2020. All Rights Reserved. Under the terms of the license agreement, an individual user may print out a PDF of a single chapter of a title in AMA Manual of Style Online for personal use (for details see Privacy Policy and Legal Notice).

date: 01 October 2020

The Ethical and Legal Considerations chapter of the 11th edition of the AMA Manual of Style summarizes best practices and cites examples of the determinants of ethical behavior and legal concerns as they relate to scientific publication. Topics covered include authorship responsibility; acknowledgments; duplicate publication; scientific misconduct; conflicts of interest; intellectual property: access, rights, and management; confidentiality; protecting research participants’ and patients’ rights in scientific publication; defamation and libel; editorial freedom and integrity; editorial responsibilities, roles, procedures, and policies; advertisements, advertorials, sponsorship, supplements, reprints, and e-prints; and release of information to the public and journal/author relations with the news media. Several new policies: mandate for a single corresponding author has been relaxed; designations such as co–first authorship or co–senior authorship may be allowed; the ICMJE policy on sharing clinical trial data is now being followed; and a new option is presented for retraction and replacement in cases of pervasive error without evidence of misconduct or invalid science.

Access to the complete content on AMA Manual of Style requires a subscription or purchase. Public users are able to search the site without a subscription.

Please subscribe or login to access full text content.

If you have purchased a print title that contains an access token, please see the token for information about how to register your code.

For questions on access or troubleshooting, please check our FAQs, and if you can't find the answer there, please contact us.